Plain-English translation of NCT06430983 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry study that collects blood samples and medical information from patients with liver cancer—both new diagnoses and cases where cancer has returned after treatment. Researchers will use this information to train computer models to recognize patterns that may help predict which patients are at higher risk of cancer recurrence. The goal is to eventually develop better tools to catch recurrent liver cancer earlier.
Liver cancer often comes back after initial treatment, but doctors don't yet have reliable ways to predict who will experience recurrence. By studying patterns in blood samples and medical histories from many patients, researchers hope to identify early warning signs that could lead to better monitoring and earlier intervention.
You likely qualify if…
You likely don't qualify if…
If you enroll, you will be asked to provide a blood sample and allow researchers to collect information from your medical records, including your age, gender, past treatments, and imaging results. Your information will be entered into a secure database and used to help develop predictive models for liver cancer recurrence. The study does not involve taking a medication or undergoing a new procedure—it is purely about contributing your data and a blood sample to advance research.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
China